Natural Immunity vs Vaccine – Explore EVERY angle

Download PDF 📄

🕒 7 min read • ✍️ 1239 words

Last Updated: Oct 6, 2021

“Largest Area of misinformation is coming from the government in regards to natural immunity”

Dr. Paul Speaks at HELP Hearing on the Science Surrounding Vaccinations – June 22, 2021 YouTube – https://youtu.be/mRrME5ixMZo

“Had COVID?
You’ll probably make antibodies for a lifetime”

A study recently published in Nature found that even after a mild covid infection, the body creates immunological memory cells that are able to quickly produce new antibodies in case of a subsequent re-infection and thus provide long-lasting immunity. The same memory cells appear to be produced after full vaccination.
Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. Researchers who have identified long-lived antibody-producing cells in the bone marrow of people who have recovered from COVID-19¹. The study provides evidence that immunity triggered by SARS-CoV-2 infection will be extraordinarily long-lasting.
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans – Nature – May 24, 2021

Had COVID? You’ll probably make antibodies for a lifetime – Nature.com, May 27, 2021

Fully vaccinated more likely than unvaccinated
to be infected by variants

“New Cleveland study shows equally protective. Those who had infection unlikely to benefit from COVID-19 vaccination”

Full Interview: https://youtu.be/kladGmD9Vlw
Just the above clip: https://rumble.com/vk5e01-rand-paul-natural-infection-vs-covid-vaccination-july-20-2021.html

New Cleveland Study he referred to:

Necessity of COVID-19 vaccination in previously infected individuals ^{⁽⁰¹⁾Preprint: Necessity of COVID-19 vaccination in previously infected individuals doi: https://doi.org/10.1101/2021.06.01.21258176}

https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v3

Spanish Flu study he referred to:

Flu Survivors Still Immune… 90 Years Later (PDF) – Hardy Diagnostics, Aug 2008 ⁽⁰²⁾Flu Survivors Still Immune… 90 Years Later (PDF) – Hardy Diagnostics, Aug 2008

Flu survivors still immune after 90 years– National Geographic, Aug 2008 ^{⁽⁰³⁾Flu survivors still immune after 90 years– National Geographic, Aug 2008}

1918 Flu Antibodies Resurrected From Elderly Survivors – ScienceDaily, Aug 2008 ^{⁽⁰⁴⁾Vanderbilt University Medical Center. “1918 Flu Antibodies Resurrected From Elderly Survivors.” ScienceDaily. ScienceDaily, 18 August 2008. <www.sciencedaily.com/releases/2008/08/080817223642.htm>.}

Natural Immunity 13 times stronger than two doses of Pfizer, Israel

**August 30th, 2021**: Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?
https://www.news-medical.net/news/20210830/Does-SARS-CoV-2-natural-infection-immunity-better-protect-against-the-Delta-variant-than-vaccination.aspx

Immunity gained naturally better protects against the Delta variant than vaccination.

This study demonstrated that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.”
https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full.pdf

“You want the minimal medical intervention to achieve the desired result – Vaccinating people after they already have antibodies? How did we get to this?”

This is a pro-vaccination doctor who isn’t getting a COVID vaccine because he has already recovered and is requesting an open-debate with authorities to recognize natural immunity.
MedStoic.com^{⁽⁰⁵⁾Dr. Suneeel Dhand – MedStoic.com} | YouTube ^{⁽⁰⁶⁾Dr. Suneel Dhand – YouTube}
https://www.youtube.com/channel/UCU-Jctu4JTEGFtVnsuqdd5Q

A long-term perspective on immunity to COVID – 14 June 2021 ^{⁽⁰⁷⁾A long-term perspective on immunity to COVID – 14 June 2021} https://www.nature.com/articles/d41586-021-01557-z
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) ^{⁽⁰⁸⁾SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)}https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection ^{⁽⁰⁹⁾Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection}https://science.sciencemag.org/content/371/6529/eabf4063
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV ^{⁽¹⁰⁾T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV}https://www.sciencedirect.com/science/article/abs/pii/S0166354216304016

What about Asymptomatic Infection?

Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection – Apr 16 2021 ^{⁽¹¹⁾Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection – Ross M. Kedl; Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection. J Exp Med 3 May 2021; 218 (5): … Click for full citation}

“Their results also support the general longevity of anti–SARS-CoV-2–specific immunity after infection. “

“Data further supports the accumulating evidence that the quantity of SARS-CoV-2-specific T cells is not proportional to disease severity during the early phase of infection”

“Though the question of protective immunity cannot be definitively answered in these data, they are sufficient to provide some confidence in reasonably lasting cellular immunity, even in post-asymptomatic infected individuals.”

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection – Mar 1 2021 ^{⁽¹²⁾Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CYL, Lim JM, Kunasegaran K, Tan LWL, Dutertre CA, Shankar N, Lim JME, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, Kalimuddin S, Lye D, Low JGH, Wang LF, Wan WY, Hsu LY, … Click for full citation}

What about those who haven’t had an Infection?

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 – Mar 15, 2021 ^{⁽¹³⁾A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 – Mar 15, 2021 Majdoubi A, Michalski C, O’Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler DF, Basappa M, Liu AC, Görges M, … Click for full citation}

“We conclude that most adults display pre-existing antibody cross-reactivity against SARS-CoV-2, which further supports investigation of how this may impact the clinical severity of COVID-19 or SARS-CoV-2 vaccine responses.”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119195/

References[+]References[−]

References
01	Preprint: Necessity of COVID-19 vaccination in previously infected individuals doi: https://doi.org/10.1101/2021.06.01.21258176
02	Flu Survivors Still Immune… 90 Years Later (PDF) – Hardy Diagnostics, Aug 2008
03	Flu survivors still immune after 90 years– National Geographic, Aug 2008
04	Vanderbilt University Medical Center. “1918 Flu Antibodies Resurrected From Elderly Survivors.” ScienceDaily. ScienceDaily, 18 August 2008. <www.sciencedaily.com/releases/2008/08/080817223642.htm>.
05	Dr. Suneeel Dhand – MedStoic.com
06	Dr. Suneel Dhand – YouTube
07	A long-term perspective on immunity to COVID – 14 June 2021
08	SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
09	Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
10	T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
11	Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection – Ross M. Kedl; Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection. J Exp Med 3 May 2021; 218 (5): e20210359. doi: https://doi.org/10.1084/jem.20210359
12	Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CYL, Lim JM, Kunasegaran K, Tan LWL, Dutertre CA, Shankar N, Lim JME, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, Kalimuddin S, Lye D, Low JGH, Wang LF, Wan WY, Hsu LY, Bertoletti A, Tam CC. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med. 2021 May 3;218(5):e20202617. doi: 10.1084/jem.20202617. PMID: 33646265; PMCID: PMC7927662.
13	A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 – Mar 15, 2021 Majdoubi A, Michalski C, O’Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler DF, Basappa M, Liu AC, Görges M, Barakauskas VE, Irvine M, Mehalko J, Esposito D, Sekirov I, Jassem AN, Goldfarb DM, Pelech S, Douek DC, McDermott AB, Lavoie PM. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight. 2021 Apr 22;6(8):e146316. doi: 10.1172/jci.insight.146316. PMID: 33720905; PMCID: PMC8119195.